A new research has raised hopes that in the future it should be possible to produce the best anti-malaria drug, artemisinin, more economically and in sufficient volumes for all patients.

Fake and poor quality anti-malarial drugs are threatening efforts to control the disease in Africa and could put millions of lives at risk, scientists say. The counterfeit medicines could harm patients and promote drug resistance among malaria parasites, warns the study, funded by the Wellcome Trust.